Discover B2B companies, suppliers, and manufacturers related to this keyword category
Cancer profiling for precision oncology and early cancer detection
First in class small molecule cancer therapeutics for hematological malignancies and select solid tumors
Striving to improve and extend patients' lives
A novel technology platform for the delivery of therapeutics across biological barriers
Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
As a leading full-service global CRO, we work to create solutions that advance new treatments from discovery to reality.
Developing allogeneic TCR-NK therapies for solid tumors
is developing disruptive therapies to address critical unmet medical needs in cancer and infectious diseases.
We are creating an entirely new Generation of Precision Medicine against Genetically Defined Diseases.
Engineering the future of targeting Natural Killer off-the-shelf cell therapy against cancer.
A clinical-stage biotech company developing a novel targeted oncolytic peptide platform to treat cancer.